Madrigal Pharmaceuticals, Inc. (MDGL)
441.16
-13.06
(-2.88%)
USD |
NASDAQ |
Mar 20, 16:00
441.32
+0.16
(+0.04%)
After-Hours: 20:00
Madrigal Pharmaceuticals Research and Development Expense (Quarterly) : 115.88M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Insmed, Inc. | 254.91M |
| Pfizer Inc. | 3.133B |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Eli Lilly & Co. | 3.802B |
| Johnson & Johnson | 4.268B |